GE HealthCare Technologies Inc. (GEHC) stock analysis

Healthcare · Medical Devices

From the 10-K filed 2026-02-04

How it makes money

GE HealthCare earns revenue by selling medical devices, consumables, and software to healthcare providers.

It sells high-tech equipment such as MRI and CT scanners, the consumable products used with them, and the software needed to operate them. These solutions are sold to hospitals and researchers in over 160 countries.

What protects it: the moat

Management claims its product portfolio and service capabilities protect its market position.

The company asserts that its wide range of solutions builds long-term trust and loyalty with customers. It also relies on a large team of field service engineers to maintain these relationships.

What growth costs

The company must reinvest in research and development to support its AI and software strategy.

To stay competitive, GE HealthCare focuses on substantial investments in R&D. These investments target technologies like AI, cloud computing, and edge computing.

What could damage it

Trade tariffs can significantly reduce operating income and cash flows.

Disputes between the U.S. and other countries result in tariffs that increase costs. In 2025, these tariffs reduced operating income by approximately $245 million.

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

More on GEHC

Other companies in Medical Devices